Before the availability of insulin therapy, diabetes was a contraindication to pregnancy. It was recommended that women with type 1 diabetes (T1D) not get pregnant.
Today, with intensive insulin therapy, many tools exist to care for people with T1D. Nevertheless, pregnant women with T1D are still considered to have high-risk pregnancies, and susceptible to complications such as fetal overgrowth, or having a large baby.
Complications of T1D and pregnancy was the topic of a presentation by Camille Powe, MD, at this year's 13th Annual Type 1 Diabetes Fellows Program. Dr. Powe is co-director of the Diabetes and Pregnancy Program at Massachusetts General Hospital at Mass General Brigham. She’s also Associate Professor of Medicine and Associate Professor of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School.
In this episode, Host Aaron Lohr talks with Dr. Powe about the range of complications associated with diabetes in pregnancy, along with insights and updates to provide the best care possible.
The T1D Fellows Program and today's episode are made possible by educational grants from our supporters, Medtronic, Dexcom, Insulate, Abbott, Vertex, Xeris, and Breakthrough T1D.
(Click below to play. Run time 36:10)
Follow us on your preferred streaming service:
